Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, September 25, 2014

The Role of Gender in MS Disease Progression and Treatment

The Science of MS Management: 
The Role of Gender in MS Disease Progression and Treatment

Corey C. Ford, MD, PhD; Rhonda Voskul, MD
CME/CE Released: 03/31/2014; Valid for credit through 03/31/2015
Faculty and Disclosures
Corey C. Ford, MD, PhD
Dr. Ford has disclosed the following financial relationships:
Sources of Funding for Research: Biogen Idec, Elan, Genentech, Genzyme, Janssen, Novartis, Ono Pharmaceutical, Sanofi Aventis, Serono, and Teva CNS.
Consulting Agreements: Biogen Idec, Novartis, and Teva CNS.
Rhonda Voskuhl, MD
Dr. Voskuhl has disclosed no relevant financial relationships.
Laurie Scudder, DNP, NP
Laurie Scudder has disclosed no relevant financial relationships.
Planners and Managers
The following planners and managers have disclosed no relevant conflicts of interest: Joseph J. D’Onofrio, Frank Marino, Nancy Monson, Katherine Wandersee.

Target Audience
This publication is targeted to neurologists and physicians who have an interest in treating multiple sclerosis (MS).
Learning Objectives
Upon completion of this educational activity, the participant should be able to:
  • Describe the role of sex hormone fluctuations on underlying pathology, disease activity, and treatment efficacy in MS
  • Discuss the therapeutic potential of hormonal therapies such as testosterone and estrogen in the management of MS
  • Review current research findings relating to sex hormones in MS, including chromosomal and genetic studies
Disclosure of Non-endorsement of Products
Approval does not imply endorsement by the CMSC or ACCME of any commercial products discussed in conjunction with an educational activity.

Disclosure of Unlabeled Use
This CME activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC, Teva CNS, and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the CMSC, Teva CNS, or Delaware Media Group.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.
Accreditation and Designation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Consortium of Multiple Sclerosis Centers (CMSC) and the Delaware Media Group. The CMSC is accredited by the ACCME to provide continuing medical education for physicians.

The CMSC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Release Date: March 31, 2014
Credit for this program expires on March 31, 2015.
Method of Participation
Follow these steps to earn CME credit:
  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. The CMSC encourages you to complete the Activity Evaluation to provide feedback for future programming.
Code: CMSC-DELMED 2014/1
Privacy Policy and Confidentiality
CMSC is committed to honoring the privacy of participants in educational activities. Our full privacy policy is available on our website at
Other Information
Jointly sponsored by the Consortium of Multiple Sclerosis Centers and Delaware Media Group.

This continuing education publication is supported by an educational grant from Teva CNS.

For questions relating to CME, please contact the CMSC at (201) 487-1050 or email
Hardware/Software Requirements
The minimum requirements for viewing an on-line book is an active internet connection and Flash (free software from Adobe) version 10 or higher.
Link to the Program
Agree Button

 Keep CURRENT and up to date, with MS News and Information

No comments: